Last week’s news that MD Anderson Cancer Center has pulled the plug on its two year partnership with IBM-Watson led many critics to wonder out loud if the machine-learning revolution is in trouble, and if Big Data could be about to become the latest tech industry buzzword to die a well-deserved death. It’s a little more complicated than that, argues HealthCatalyst’s Dale Sanders in this can’t-miss presentation. The problems with the MD Anderson-Watson partnership probably say more about the “Big Data Industry” and the goings-on at IBM as they do about the technology. Still, there are important lessons we can learn from the episode.
- “Big Data Bust: MD Anderson IBM Watson Project Dies” (Medscape, Feb 22)
- “MD Anderson Benches IBM Watson in Setback For Artificial Intelligence”
(Forbes, Feb 19) - “As Rometty Prepares to Open HIMSS, MD Anderson Walks Away…”
(MedCity News, Feb 19″) - “Watson Can’t Cure Cancer .. or the Stuff That Breaks IT Projects” (The Register, Feb 20)

Reports coming out of Washington suggest that Republicans may have bitten off more than they would like to chew with repealing & replacing the ACA, with a
The economic fundamentals of healthcare in the United States are unique, amazingly complex, multi-layered and opaque. It takes a lot of work and time to understand them, work and time that few of the experts opining about healthcare on television have done. Once you do understand them, it takes serious independence, a big ornery streak, and maybe a bit of a career death wish to speak publicly about how the industry that pays your speaking and consulting fees should, can, and must strive to make half as much money. Well, I turn 67 this year and I’m cranky as hell, so let’s go.
As policymakers debate